Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions
Open Access
- 10 September 2021
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 12 (2) , 532-557
Abstract
No abstract availableKeywords
This publication has 143 references indexed in Scilit:
- Repositioning metformin for cancer prevention and treatmentTrends in Endocrinology & Metabolism, 2013
- Diverse age-related effects of Bacopa monnieri and donepezil in vitro on cytokine production, antioxidant enzyme activities, and intracellular targets in splenocytes of F344 male ratsInternational Immunopharmacology, 2013
- Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like PropertiesJournal of Medicinal Chemistry, 2012
- Evolutionarily Repurposed Networks Reveal the Well-Known Antifungal Drug Thiabendazole to Be a Novel Vascular Disrupting AgentPLOS Biology, 2012
- A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer TreatmentCancer Discovery, 2011
- Peroxisome proliferator-activated receptor γ agonist pioglitazone inhibits β-catenin-mediated glioma cell growth and invasionMolecular and Cellular Biochemistry, 2011
- Carvedilol in glioma treatment alone and with imatinib in vitroInternational Journal of Oncology, 2010
- The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancerGut, 2009
- Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic targetInternational Journal of Cancer, 2009
- Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cellsMolecular Cancer, 2009